✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Kimia Biosciences Ltd.

KIMIABL

Market Cap
₹203 Cr.
P/E
21.55

Kimia Biosciences Ltd.

  • Kimia Biosciences
  • Panchsheel Organics
  • Alpa Lab
FAQs on Kimia Biosciences Ltd. Shareprice

Kimia Biosciences has given better returns compared to its competitors.
Kimia Biosciences has grown at ~-3.28% over the last 3yrs while peers have grown at a median rate of -4.64%

Kimia Biosciences is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Kimia Biosciences is 21.76, while 3 year average PE is 16.04.
Also latest EV/EBITDA of Kimia Biosciences is 14.64 while 3yr average is 1041.

View FAQ's On Business
Growth Table
  • Kimia Biosciences Ltd.
  • Panchsheel Organics
  • Alpa Lab
Balance Sheet
  • Kimia Biosciences Ltd.
  • Panchsheel Organics
  • Alpa Lab
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Kimia Biosciences Ltd.
  • Panchsheel Organics
  • Alpa Lab
Cash Flow
  • Kimia Biosciences Ltd.
  • Panchsheel Organics
  • Alpa Lab
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Kimia Biosciences Ltd.
  • Panchsheel Organics
  • Alpa Lab
Quarterly Results
  • Kimia Biosciences Ltd.
  • Panchsheel Organics
  • Alpa Lab
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Kimia Biosciences Ltd. Financials

Balance sheet of Kimia Biosciences is moderately strong, But short term working capital might become an issue for this company.

The debt of Kimia Biosciences is decreasing.
Latest debt of Kimia Biosciences is ₹32.8 Crs as of Dec-24.
This is less than Mar-24 when it was ₹42.48 Crs.

Yes, profit is increasing.
The profit of Kimia Biosciences is ₹9.42 Crs for TTM, -₹5.31 Crs for Mar 2024 and -₹9.35 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kimia Biosciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech